14/10/05

Tailoring medicines to Chinese genes

Does personalised medicine have a future in China? Copyright: IRD / Montoroi

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:

You have to credit our authors.
You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
The easiest way to get the article on your site is to embed the code below.

For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

<div class="article-wrap">
<div id="article-introduction">
<h1>Tailoring medicines to Chinese genes</h1>
<h4></h4>
</div>
<br />
<br />

<div id="article-body">
<p><P>The promise of tailoring medicines to a person’s genetic makeup has captured the imagination of healthcare professionals. Now, researchers are trying to introduce it to one of the world’s biggest health markets — China.</P><br />
<P>In this article, Matt Young reports on how biotechnology companies are starting to investigate the potential for testing and marketing personalised drugs in China. </P><br />
<P>Private companies are developing cheap ‘DNA chips’ to screen people for genes that should show how well they would react to a particular drug, or how high a dose they might need.</P><br />
<P>And, as a Chinese biotechnologist points out, drugs that the US does not consider to be effective enough for its population might work in Asians.</P><br />
<P>But international pharmaceutical companies say they would be reluctant to develop a drug exclusively for the Chinese market. </P><br />
<P>In addition, the companies are shying away from developing China-specific drugs because of the country’s lack of adequate patent protection.</P>Despite these obstacles, the time is ripe to pursue personalised medicine in China, says one Beijing scientist. Because many parts of the country are untouched by immigration, geneticists could find it easier to pinpoint a disease-causing gene, he says.<BR><BR><a  href="http://www.atimes.com/atimes/China_Business/GJ06Cb01.html" target="_blank" onclick="pageTracker._trackPageview('/tracking/external/'+this.href);" rel="noopener noreferrer">Link to full article in <EM>Asia Times Online</EM></A><BR><BR></p>

</div>
<div class="quick-links-wrapper">
<h3>You might also like</h3>
[related-articles]
</div>
<p>This article was originally published on <a href="https://www.scidev.net" target="_blank">SciDev.Net</a>. Read the <a href="https://www.scidev.net/global/features/tailoring-medicines-to-chinese-genes/" target="_blank">original article</a>.</p>
<script type="text/javascript">
(function(e,t,n,r,i,s,o){e["GoogleAnalyticsObject"]=i;e[i]=e[i]||function(){(e[i].q=e[i].q||[]).push(arguments)},e[i].l=1*new Date;s=t.createElement(n),o=t.getElementsByTagName(n)[0];s.async=1;s.src=r;o.parentNode.insertBefore(s,o)})(window,document,"script","//www.google-analytics.com/ga.js","ga");var _gaq=_gaq||[];var _gaq=_gaq||[];_gaq.push(["_setAccount","UA-3223906-8"],["_trackEvent","article interaction","republished","https://www.scidev.net/global/features/tailoring-medicines-to-chinese-genes/",null,true])
</script>
</div>

The promise of tailoring medicines to a person’s genetic makeup has captured the imagination of healthcare professionals. Now, researchers are trying to introduce it to one of the world’s biggest health markets — China.

In this article, Matt Young reports on how biotechnology companies are starting to investigate the potential for testing and marketing personalised drugs in China.

Private companies are developing cheap ‘DNA chips’ to screen people for genes that should show how well they would react to a particular drug, or how high a dose they might need.

And, as a Chinese biotechnologist points out, drugs that the US does not consider to be effective enough for its population might work in Asians.

But international pharmaceutical companies say they would be reluctant to develop a drug exclusively for the Chinese market.

In addition, the companies are shying away from developing China-specific drugs because of the country’s lack of adequate patent protection.

Despite these obstacles, the time is ripe to pursue personalised medicine in China, says one Beijing scientist. Because many parts of the country are untouched by immigration, geneticists could find it easier to pinpoint a disease-causing gene, he says.

Link to full article in Asia Times Online